Tag: Dr Mimi Tang

Professor Mimi Tang

Researchers Find Gene Mechanism Behind Peanut Allergy Remission with Potential for...

Key immunological changes that support the remission of peanut allergy in children will pave the way for new, more targeted treatments.
Prota Therapeutics

Prota Therapeutics Achieves 51% Peanut Allergy Remission Rate in Kids with...

Children's ability to eat peanut freely and safely delivers meaningful improvement in quality of life for families and patients.
Lactobacillus rhamnosus

Mixed Results from Study of Probiotic Added to Oral Immunotherapy (OIT)

The addition of the probiotic did not improve the effectiveness of OIT but did enhance tolerability of the treatment.
Baby

Recruitment of Infants Begins for Phase 3 Trial of Cream to...

The trial needs 760 babies aged three weeks or younger whose parents or siblings suffer from either eczema, asthma or food allergies.
Lactobacillus rhamnosus

Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate

Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.
L-rhamnosus

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

Exciting news of lasting peanut tolerance four years after Probiotic + Peanut OIT treatment.

Peanut Allergy Treatment Receives Funding for Commercialization

"There’s a clear path to a marketable product here that could have tremendous impact globally."
Professor Mimi Tang

News from Australia: Hospital Admissions for Anaphylaxis Jump

More children are developing food allergies of the type that are not typically grown out of.